News
- Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
05/10/2019 / 07:00 - GlobeNewswire
-
- Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual Meeting
05/08/2019 / 07:00 - GlobeNewswire
-
- Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting
05/07/2019 / 07:00 - GlobeNewswire
-
- FDA approves Roche's Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment
05/06/2019 / 07:00 - GlobeNewswire
-
- New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio
04/29/2019 / 07:00 - GlobeNewswire
-
- Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
04/26/2019 / 07:00 - GlobeNewswire
-
- Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy
04/23/2019 / 07:00 - GlobeNewswire
-
- Consolidated Research: 2019 Summary Expectations for Shoe Carnival, ARC Document Solutions, Tidewater, Rogers, Charah Solutions, and Azure Power Global — Fundamental Analysis, Key Performance Indications
04/09/2019 / 13:55 - GlobeNewswire
-
- Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
04/03/2019 / 07:00 - GlobeNewswire
-
- Roche's ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial
04/01/2019 / 07:00 - GlobeNewswire
Real-time